vaccines

Shares of German biotechnology firm CureVac nearly tripled in their Nasdaq debut Friday, marking the first stock market debut of a company developing a potential vaccine to combat the novel coronavirus. The stock opened at $44 per share, up from the initial public offering price of $16 per share. CureVac, backed by Microsoft founder and …

Americans likely won’t have to pay for a coronavirus vaccine once researchers have one ready, according to reports. The US government plans to pick up the tab for the hundreds of millions of vaccine doses that pharmaceutical firms are racing to produce, the Wall Street Journal reported. The feds are also reportedly talking with insurance …

The European Commission has placed its first official order for a coronavirus vaccine with a deal to buy 300 million doses of AstraZeneca’s experimental shot, officials said Friday. The body plans to donate vaccines to lower- and middle-income countries through its agreement with the British drugmaker, which gives it the option to buy another 100 …

As Russia claims victory in the race to a successful coronavirus vaccine, scientists are warning against haphazardly adopting the vaccine without testing it sufficiently. Moscow announced Tuesday that Russia has approved a coronavirus vaccine that has proven successful in testing and provides lasting immunity, making Russia the first country to register a vaccine against the pandemic. …

The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine for around $1.5 billion, the company and White House said on Tuesday. The United States in recent weeks has made deals to acquire hundreds of millions of doses of potential COVID-19 vaccines from several companies …

Former Food and Drug Administration commissioner Scott Gottlieb sounded a note of caution on Tuesday against Russia’s claim to have produced a vaccine for the coronavirus. Russian president Vladimir Putin announced on Tuesday morning that his country had discovered the first effective treatment for the coronavirus, calling the vaccine “Sputnik V.” However, Gottlieb said that …

As many as one in three Americans say they would not get a vaccine for the coronavirus even if it were approved by the FDA and available for free. About 35 percent of Americans say they would not receive such a vaccine to guard against the coronavirus, while 65 percent say they would plan to …

The feds will give Sanofi and GlaxoSmithKline up to $2.1 billion to churn out a coronavirus vaccine in the Trump administration’s latest and largest bet on an experimental inoculation. More than half the award announced Friday will help the European drugmakers develop and test their vaccine, while the rest will be used to support manufacturing …

Johnson & Johnson kicked off human trials of its experimental COVID-19 vaccine Thursday, after the shots already proved successful in protecting monkeys, the drugmaker announced. Company honchos pointed to a new study which found that five out of six primates who got the single-dose shot were protected from infection when exposed to the coronavirus, as …

Drug maker Moderna started the final round of clinical testing for its coronavirus vaccine on Monday, making it the first candidate to enter a crucial stage of research in the US and sending it shares up 10 percent. The Cambridge, Mass.-based company’s Phase 3 trial will test its experimental inoculation in about 30,000 people at …